Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 16INDUSTRY 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Leukemia 81Breast Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Lymphoma 40Leukemia, Myeloid, Acute 33Neoplasms 29Colorectal Neoplasms 26Sarcoma 24Congenital Abnormalities 24Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Neuroblastoma 19Ovarian Neoplasms 17Rectal Neoplasms 15Osteosarcoma 15Leukemia, Lymphocytic, Chronic, B-Cell 15Colonic Neoplasms 15Wilms Tumor 14Melanoma 14Multiple Myeloma 13Lymphoma, Follicular 13Leukemia, Myelomonocytic, Acute 13Leukemia, Megakaryoblastic, Acute 13Kidney Neoplasms 13Leukemia, Monocytic, Acute 12Leukemia, Erythroblastic, Acute 12HIV Infections 12Central Nervous System Neoplasms 12Lymphoma, Non-Hodgkin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Observational × Hereditary Breast and Ovarian Cancer Syndrome × Clear all
NCT01445275 2024-08-21

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

GOG Foundation

Withdrawn
BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡